117 related articles for article (PubMed ID: 27429126)
1. Allosteric Sensing of Fatty Acid Binding by NMR: Application to Human Serum Albumin.
Jafari N; Ahmed R; Gloyd M; Bloomfield J; Britz-McKibbin P; Melacini G
J Med Chem; 2016 Aug; 59(16):7457-65. PubMed ID: 27429126
[TBL] [Abstract][Full Text] [Related]
2. Determining molecular binding sites on human serum albumin by displacement of oleic acid.
Sarver RW; Gao H; Tian F
Anal Biochem; 2005 Dec; 347(2):297-302. PubMed ID: 16289007
[TBL] [Abstract][Full Text] [Related]
3. Carrier-protein-mediated enhancement of fatty-acid binding and internalization in human T-lymphocytes.
Uriel J; Torres JM; Anel A
Biochim Biophys Acta; 1994 Feb; 1220(3):231-40. PubMed ID: 7508265
[TBL] [Abstract][Full Text] [Related]
4. Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy.
Simard JR; Zunszain PA; Ha CE; Yang JS; Bhagavan NV; Petitpas I; Curry S; Hamilton JA
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):17958-63. PubMed ID: 16330771
[TBL] [Abstract][Full Text] [Related]
5. Imatinib binding to human serum albumin modulates heme association and reactivity.
Di Muzio E; Polticelli F; Trezza V; Fanali G; Fasano M; Ascenzi P
Arch Biochem Biophys; 2014 Oct; 560():100-12. PubMed ID: 25057771
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization.
Fanali G; Fesce R; Agrati C; Ascenzi P; Fasano M
FEBS J; 2005 Sep; 272(18):4672-83. PubMed ID: 16156788
[TBL] [Abstract][Full Text] [Related]
7. Correspondence of fatty acid and drug binding sites on human serum albumin: a two-dimensional nuclear magnetic resonance study.
Krenzel ES; Chen Z; Hamilton JA
Biochemistry; 2013 Mar; 52(9):1559-67. PubMed ID: 23360066
[TBL] [Abstract][Full Text] [Related]
8. 1H-NMR study on the interactions of human serum albumin with free fatty acid.
Oida T
J Biochem; 1986 Dec; 100(6):1533-42. PubMed ID: 3571185
[TBL] [Abstract][Full Text] [Related]
9. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
Simard JR; Zunszain PA; Hamilton JA; Curry S
J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
[TBL] [Abstract][Full Text] [Related]
10. Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding.
Kaneko K; Chuang VT; Minomo A; Yamasaki K; Bhagavan NV; Maruyama T; Otagiri M
IUBMB Life; 2011 Apr; 63(4):277-85. PubMed ID: 21488149
[TBL] [Abstract][Full Text] [Related]
11. Chromatographic analysis of the effects of fatty acids and glycation on binding by probes for Sudlow sites I and II to human serum albumin.
Anguizola J; Debolt E; Suresh D; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():175-181. PubMed ID: 26468085
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-chain Fatty acids on the binding of triflupromazine to human serum albumin: a spectrophotometric study.
Kitamura K; Takegami S; Tanaka R; Omran AA; Kitade T
Sci Pharm; 2014; 82(2):233-45. PubMed ID: 24959397
[TBL] [Abstract][Full Text] [Related]
13. NMR metabolomics profiling of blood plasma mimics shows that medium- and long-chain fatty acids differently release metabolites from human serum albumin.
Jupin M; Michiels PJ; Girard FC; Spraul M; Wijmenga SS
J Magn Reson; 2014 Feb; 239():34-43. PubMed ID: 24374750
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the pleiotropic effects of human serum albumin in health and disease.
Ha CE; Bhagavan NV
Biochim Biophys Acta; 2013 Dec; 1830(12):5486-93. PubMed ID: 23602811
[TBL] [Abstract][Full Text] [Related]
15. Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin--an optical and NMR spectroscopic investigation.
Fanali G; Pariani G; Ascenzi P; Fasano M
FEBS J; 2009 Apr; 276(8):2241-50. PubMed ID: 19298387
[TBL] [Abstract][Full Text] [Related]
16. Conformational changes and allosteric communications in human serum albumin due to ligand binding.
Ahalawat N; Murarka RK
J Biomol Struct Dyn; 2015; 33(10):2192-204. PubMed ID: 25495718
[TBL] [Abstract][Full Text] [Related]
17. NMR identification of endogenous metabolites interacting with fatted and non-fatted human serum albumin in blood plasma: Fatty acids influence the HSA-metabolite interaction.
Jupin M; Michiels PJ; Girard FC; Spraul M; Wijmenga SS
J Magn Reson; 2013 Mar; 228():81-94. PubMed ID: 23357430
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia.
Mothes E; Faller P
Biochemistry; 2007 Feb; 46(8):2267-74. PubMed ID: 17274600
[TBL] [Abstract][Full Text] [Related]
19. Serum albumin as a primary non-covalent binding protein for nitro-oleic acid.
Hernychova L; Alexandri E; Tzakos AG; Zatloukalová M; Primikyri A; Gerothanassis IP; Uhrik L; Šebela M; Kopečný D; Jedinák L; Vacek J
Int J Biol Macromol; 2022 Apr; 203():116-129. PubMed ID: 35063491
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
Fujiwara S; Amisaki T
Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
